Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial

PURPOSE: Microbiological diagnosis (MD) of infections remains insufficient. The resulting empirical antimicrobial therapy leads to multidrug resistance and inappropriate treatments. We therefore evaluated the cost-effectiveness of direct molecular detection of pathogens in blood for patients with se...

Descripción completa

Detalles Bibliográficos
Autores principales: Cambau, Emmanuelle, Durand-Zaleski, Isabelle, Bretagne, Stéphane, Brun-Buisson, Christian, Cordonnier, Catherine, Duval, Xavier, Herwegh, Stéphanie, Pottecher, Julien, Courcol, René, Bastuji-Garin, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633620/
https://www.ncbi.nlm.nih.gov/pubmed/28374097
http://dx.doi.org/10.1007/s00134-017-4766-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633620/
https://www.ncbi.nlm.nih.gov/pubmed/28374097
http://dx.doi.org/10.1007/s00134-017-4766-4

Ejemplares similares